YY/T 1416.3-2016Test method for additive in single-use containers for human venous blood specimen collection - Part 3: Heparin (English PDF)
一次性使用人体静脉血样采集容器中添加剂量的测定方法第3部分:肝素
This is a limited preview
Buy now to download the full PDF (18 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1416.3-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
July 29, 2016
Implementation date
June 1, 2017
Scope
YY/T 1416.3-2016 is the English-translated version of 一次性使用人体静脉血样采集容器中添加剂量的测定方法第3部分:肝素.
YY/T 1416.3-2016 is the Chinese pharmaceutical industry standard that gives the methylene blue spectrophotometric method for determining the amount of heparin additive in a single-use venous blood collection container.
It is the third part of the YY/T 1416 series and sets out the reagents, the extraction from the tube, the colour reaction and its measurement and the calculation of the heparin per container. Issued on 29 July 2016, it has applied since 1 June 2017.
Found what you need?
Document preview — YY/T 1416.3-2016
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- Introduction4
- 1 Scope5
- 2 Normative references5
- 3 Test section5
- 4 Test report7
Introduction
Single-use containers for human venous blood specimen collection (abbreviated as blood-collecting vessel) and single-use needle for sterile venous blood specimen collection shall be used together. Venous blood samples shall be collected for clinical test. The use of blood-collecting vessels which contain different additives or addenda are different. Heparin is widely distributed in almost all tissues, such as lung, liver and spleen, and in the granule of mast cells and basophilic granulocytes around blood vessels. Heparin can enhance the inactivation from antithrombin III (AT-III) to serine proteases, therefore, it can prevent the formation of thrombin and prevent several kinds of anticoagulation such as platelet aggregation. Although heparin can maintain the natural morphology of red blood cells, however, it often causes leukocyte aggregation, and when smears are used for Roche staining, blue background can be produced.
Therefore, heparin anticoagulation is not suitable for general whole-hematology examinations. Heparin is the ideal anticoagulant for red-blood-cell permeability test.
YY 0314 only gives the concentration range of heparin sodium / heparin lithium. This part of YY/T 1416 gives the method for determining the amount of each additive.
This section recommends methylene blue spectrophotometric method to determine the amount of additive "heparin sodium / heparin lithium" in single blood-collecting vessel, so as to facilitate the quality control of single-use containers for human venous blood specimen collection. Other methods of measurement may also be used, but methodological confirmation shall be required.
1 Scope
This Part of YY/T 1416 specifies the experiment method of using methylene blue spectrophotometric method to determine the amount of additive "heparin" in single-use containers for human venous blood specimen collection (abbreviated as blood-collecting vessel).
This Part applies to the blood-collecting vessel whose additive is heparin lithium / heparin sodium.
2 Normative references
The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) are applicable to this standard.
GB/T6682 Water for analytical laboratory use - Specification and test method
3 Test section
3.1 Test principle
This Part is the experiment method of using methylene blue spectrophotometric method to determine the potency of heparin lithium / heparin sodium in blood-collecting vessel; it uses heparin to react with the methylene blue solution to conduct the fading reaction; and it determines the content of heparin lithium / heparin sodium by the relation that the decrease in absorbance is proportional to the concentration of heparin in solution.
3.2 Instruments and reagents
Unless otherwise specified, the reagents used shall be analytically pure; the test water shall meet the requirements for Grade-2 water specified in GB/T 6682.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 18 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1416.3-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 6682-2008 — Water for analytical laboratory use - Specification and test methods
YY/T 1416.4-2016 — Test method for additive in single-use containers for human venous blood specimen collection - Part 4: Fluoride
YY/T 1416.2-2016 — Test method for additive in single-use containers for human venous blood specimen collection - Part 2: Sodium citrate
Secure payment via Stripe
Payments accepted
YY/T 1416.3-2016
$89.00